SAB Biotherapeutics Inc (SABSW)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Assets | 52.51M | 50.91M | 42.67M | 35.44M | 28.34M | 83.94M | 71.37M | 61.89M |
Total Current Assets | 22.18M | 22.1M | 15.03M | 9.01M | 3.13M | 58.91M | 46.95M | 39.58M |
Cash and Equivalents | 8.33M | 15.05M | 13.06M | 7.77M | 2.43M | 56.57M | 14.03M | 17.24M |
Total Non-Current Assets | 50.44M | 48.16M | 46.14M | 44.22M | 42.11M | 41.1M | 38.68M | 35.61M |
Total Liabilities | 21.88M | 19.85M | 18.27M | 15.73M | 13.08M | 26.64M | 18.55M | 15.77M |
Total Current Liabilities | 17.1M | 14.99M | 13.67M | 11.01M | 9.21M | 10.81M | 8.3M | 7.55M |
Total Non-Current Liabilities | 8.45M | 9.03M | 8.74M | 8.74M | 7.32M | 19.25M | 13.63M | 11.57M |
Common Equity | 4k | 5k | 5k | 5k | 5k | 1,000 | 1,000 | 1,000 |
Retained Earnings | -40M | -47.87M | -55.22M | -62.11M | -67.21M | -90.06M | -95.09M | -102.43M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 322k | 79.37M | 50.91M | 83.94M |
Total Current Assets | 87k | 48.42M | 22.1M | 58.91M |
Cash and Equivalents | 85k | 33.21M | 15.05M | 56.57M |
Total Non-Current Assets | 16k | 38.55M | 31.06M | 57.3M |
Total Liabilities | 306k | 40.82M | 19.85M | 26.64M |
Total Current Liabilities | 306k | 24.68M | 14.99M | 10.81M |
Total Non-Current Liabilities | 0 | 19.9M | 9.03M | 19.25M |
Total Equity | 16k | 38.55M | 31.06M | 57.3M |
Common Equity | 0 | 4k | 5k | 1,000 |
Retained Earnings | -9k | -29.13M | -47.87M | -90.06M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.